Clincosm LogoSign in Get a demo

pulmonary vascular resistance abnormality

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PV Loop and Pulmonary Hypertension

Recruiting
  • Pulmonary Vascular Resistance Abnormality
  • Measuring VA Coupling
  • San Francisco, California
  • +1 more
Jul 29, 2022

Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 6

Recruiting
  • Hypertension, Pulmonary
  • +2 more
  • levosimendan at a dose of 6 mcg/kg
  • milrinone at a dose of 50 mcg/kg
  • Athens, Greece
    Onassis Cardiac Surgery Center
Feb 8, 2022

Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 3

Recruiting
  • Hypertension, Pulmonary
  • +2 more
  • levosimendan at a dose of 3 mcg/kg
  • +2 more
  • Athens, Greece
    Onassis Cardiac Surgery Center
Feb 8, 2022

ET1 Concentration, Metabolic Pathway Activation, and Pulmonary

Recruiting
  • Single-ventricle
  • +4 more
  • Research Blood Sampling
  • Denver, Colorado
    Children's Hospital Colorado
Aug 16, 2021

Iron-deficiency, Ventricular Function, Pulmonary Vascular Resistance Abnormality Trial (Ferric Carboxymaltose Injectable

Completed
  • Iron-deficiency
  • +3 more
  • Ferric Carboxymaltose Injectable Product
  • Normal Saline 0.9% Infusion Solution Bag
  • (no location specified)
Oct 16, 2018

Pulmonary Hypertension, Mirabegron, Heart Failure Trial (Mirabegron, Placebo)

Unknown status
  • Pulmonary Hypertension
  • +3 more
  • (no location specified)
May 16, 2016